Hide Board Information

Show Board Information

Alchemy Creative Inc ALMY

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/07/2021 5:38:53 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 4

Alchemy Creative Inc (OTCMRKTS: ALMY) Stock Message Board

1. ALMY Company Profile

    

2. ALMY Time & Sales

    

3. ALMY Recent News

    

4. ALMY Filings

    

5. ALMY Financials

    

6. ALMY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	Nice move up 42%!	ih8aloss	05/07/2021 5:38:53 PM
6	ALMY 255% v1,37M c.039 H.04 do-do-do-do, do-do	znewcar1	04/30/2021 4:23:24 PM
5	Check out QTMM - Quantum Materials Corp also.	ih8aloss	04/13/2021 4:12:35 PM
4	https://alchemycreativeco.com/ is the site	ih8aloss	04/12/2021 11:46:49 PM
3	ALMY 0.0001 Stock Charts $ALMY 1 Month Chart	chartguy89	03/05/2014 8:56:54 PM
2	ALMY Stock Charts Saturday, February 22, 2014 at	chartguy89	02/22/2014 7:39:56 AM
1	ALMY Stock Chart 0.0001 Saturday, February 8,	chartguy89	02/08/2014 3:55:44 AM

Recent Articles

• Aeroméxico's Exciting Global Offering: What You Need to Know
• Investigation Into Luminar Technologies Signals Serious Concerns
• Inquiry into Hasbro Leadership: Legal Investigation Unfolds
• Legal Investigation of CVS/Aetna Medicare Advantage Claims
• Deadline Approaches for Dow Investors in Class Action Case
• Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
• Fluor Corporation Lawsuit Update: Important Investor Info
• Investors Urged to Act Before KBR Class Action Deadline
• Cytokinetics Class Action Lawsuit Update: Important Deadlines
• Important Legal Update for WPP Investors: Key Deadline Approaches
• Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
• Marex Group Faces Class Action Lawsuit Over Financial Misconduct
• Lead the Charge: Join the Fly-E Group Securities Lawsuit
• Investigation into MoonLake Immunotherapeutics Raises Concerns
• MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
• Investigation of MoonLake Immunotherapeutics Raises Concerns
• Leadership Changes at Silver Mountain Resources: What to Expect
• Canton Fair Launches Enhanced Services to Boost Global Trade
• rYojbaba's Global Outreach: Enhancing Health and Legal Aid Services
• Empowering Conversations on Motherhood and Health Initiatives
• The Wealth Growth Journey of Insight Enterprises Stock
• Exploring Sterling Infrastructure's Impressive Stock Growth Over 15 Years
• Flagstar Bank, N.A. Completes Strategic Holding Company Shift
• Baxter International Inc. Faces Class Action Lawsuit Challenges
• StoneX Enhances Wealth Management Services for Latin America
• The Impact of Long-Term Investment in Commercial Metals
• Transforming Healthcare Marketing: Salubrum's AI Innovation
• StoneX Enhances Wealth Management for Latin American Clients
• The Growth Journey of Tapestry: A Decade in Review
• Quantum Corporation Investors Urged to Act Before Deadline
• WhippleWood CPAs Partners to Transform Client Engagement with Tech
• Investing in First Solar Stock: A Five-Year Review
• Mirror Lake Inn Resort and Spa: Northeast's Top Choice for Luxury
• United Lithium's Strategic Acquisition to Enhance Market Position
• PeopleGuru Holdings Faces Legal Action After Data Breach Incident
• The Remarkable Growth of Comfort Systems USA Investments
• Zions Bancorporation Under Investigation: Key Facts for Investors
• United Lithium's Strategic Move to Enhance Nordic Metals Portfolio
• Understanding the Historic Growth of United Rentals Stock
• Legal Inquiry Launched for Merger Investigation of Major Firms
• GRAIL's PATHFINDER 2 Study Revolutionizes Early Cancer Detection
• Investors Alert: Tronox Holdings PLC Class Action Reminders
• Understanding Spotify Technology's Investment Growth Over Time
• How $100 in Canadian Natural Resources Grows Over 5 Years
• Baxter International Faces Class Action from Investors Amid Concerns
• Understanding Jacobs Solutions: A Price-to-Earnings Analysis
• Virtual Field Surpasses 4 Million Eye Exams Transforming Diagnostics
• Welltower's Remarkable Growth: $100 Investment Today Worth $1571
• Marex Group PLC Shareholders: Class Action Info and Updates
• FDA Approval for Rybelsus®: A Game Changer for Diabetes Care